iOSAT 130mg Review: The FDA-Approved Gold Standard for Radiation Protection
FDA Verified — NDA Approved Since 1982When the United States government needs potassium iodide tablets for national stockpiles, they turn to one product: iOSAT, manufactured by Anbex, Inc. This isn't marketing — it's a verifiable fact. iOSAT holds the longest continuous FDA approval of any potassium iodide product in America, dating back to 1982, and carries National Stock Number 6505-01-496-4916 for Department of Defense procurement.
For individuals building a serious nuclear emergency preparedness kit, iOSAT represents the gold standard. Each 130mg tablet delivers a full adult dose of potassium iodide in a single, individually foil-sealed package with an industry-maximum 10-year shelf life. But is it the right choice for everyone? Let's break down the details.
| Manufacturer | Anbex, Inc. (Virginia, USA) |
|---|---|
| FDA Status | NDA-Approved (since 1982) |
| NDC Number | 51803-001 |
| Strength | 130mg potassium iodide per tablet |
| Count | 14 tablets per pack |
| Form | Round white tablet, double-scored |
| Shelf Life | 10 years (current stock: July 2032+) |
| Price | ~$19.95 (14 tablets) |
| Inactive Ingredients | Microcrystalline cellulose, magnesium stearate, silicon dioxide, sodium thiosulfate |
| NSN | 6505-01-496-4916 |
About the Manufacturer: Anbex, Inc.
Anbex, Inc. is a Virginia-based pharmaceutical company that has been the primary supplier of potassium iodide to the U.S. government for over four decades. Their products are distributed to the Department of Defense (DoD), Department of Homeland Security (DHS), and Department of Health and Human Services (HHS). This government contractor status means iOSAT undergoes rigorous quality control that exceeds standard commercial pharmaceutical requirements.
Anbex has publicly warned consumers about counterfeit potassium iodide products appearing on Amazon and other marketplaces. The company recommends purchasing only from authorized distributors — SurvivalFrog being one of the few authorized online retailers in the United States.
40+ Years of FDA Approval
iOSAT's FDA approval dates to 1982, making it the longest-standing approved potassium iodide product in the United States. The product was approved under a New Drug Application (NDA), which is a more rigorous pathway than the Abbreviated New Drug Application (ANDA) used by generic competitors. This means Anbex submitted original clinical data demonstrating safety, efficacy, and bioavailability.
You can verify iOSAT's FDA status yourself by searching for NDC 51803-001 on the FDA's DailyMed database. The listing confirms the product's approved labeling, inactive ingredients, and manufacturing standards.
Additionally, iOSAT has been validated through the FDA's Shelf Life Extension Program (SLEP), which tests government-stockpiled medications years beyond their labeled expiration. Testing has consistently shown that properly stored iOSAT tablets maintain full potency well beyond their 10-year label.
Dosing and Administration
Each iOSAT tablet contains 130mg of potassium iodide — a full adult dose as defined by the FDA and CDC. The tablet is double-scored, meaning it has two intersecting lines allowing it to be split into halves (65mg) or quarters (32.5mg) for pediatric dosing.
For adults aged 18–40, the dose is simple: one tablet per day, taken as directed by public health officials during a radiation emergency. Adults over 40 should take iOSAT only at higher projected thyroid exposure levels (>500 cGy), as the risk-benefit ratio shifts with age.
For children, dosing requires tablet splitting: children 3–12 receive half a tablet (65mg), children 1 month to 3 years receive a quarter tablet (32mg), and neonates receive an eighth of a tablet (16mg). While the double-scoring helps, splitting 130mg tablets accurately for infant doses can be challenging — which is why families with young children may prefer ThyroSafe 65mg tablets instead.
Industry-Maximum 10-Year Shelf Life
iOSAT's 10-year shelf life is the longest of any commercial potassium iodide product. Each tablet is individually sealed in pharmaceutical-grade foil packaging, protecting against moisture, light, and oxidation — the three factors that could theoretically degrade KI over time.
Current production batches carry expiration dates extending to July 2032 and beyond. According to the Nuclear Regulatory Commission (NRC), potassium iodide tablets are "inherently stable" and "do not lose their effectiveness over time" when properly stored. This means iOSAT purchased today will likely remain fully effective for decades, though the 10-year expiration represents the manufacturer's guarantee period.
Storage Recommendations
Store iOSAT in its original sealed packaging at room temperature (59–86°F / 15–30°C) in a dry location away from direct light. A bedroom closet or dedicated emergency supplies shelf is ideal. Avoid storing in bathrooms (humidity) or garages (temperature extremes). For travel preparedness, the 5-count travel pack fits easily in a vehicle glove compartment.
✓ Pros
- FDA NDA-approved since 1982 — longest track record of any KI product
- 10-year shelf life — industry maximum, ideal for long-term stockpiling
- Individually foil-sealed — maximum protection against degradation
- U.S. government contractor — DoD, DHS, HHS procurement credibility
- Simple one-tablet adult dose — no counting or doubling needed
- Made in USA by Anbex, Inc. (Virginia)
✕ Cons
- Most expensive per-tablet of any KI product (~$1.43/tablet)
- Tablet splitting required for all pediatric doses — less precise than 65mg tablets
- 14-tablet packs mean families need multiple packs (or bulk 10-pack)
- Available through fewer retail channels than supplement alternatives
- Overkill for daily thyroid supplement use (130mg = ~800x daily iodine requirement)
Who Should Buy iOSAT?
iOSAT is the best choice for: Adult-only households, serious preppers and survivalists who want maximum shelf life and government-grade quality, anyone planning to stockpile KI for 10+ years, and individuals within the 10-mile Emergency Planning Zone (EPZ) of a nuclear power plant who want the most reliable product available.
Consider alternatives if: You have children under 12 (see ThyroSafe 65mg for easier pediatric dosing), budget is a primary concern (see ThyroShield supplement), or you need large quantities at lower cost.
Where to Buy iOSAT
$19.95
How to Verify iOSAT's FDA Status
- Visit DailyMed (dailymed.nlm.nih.gov)
- Search for NDC number: 51803-001
- Confirm the listing shows "Potassium Iodide" by "Anbex Inc."
- Check that the approval type is NDA (New Drug Application)
Frequently Asked Questions
Yes. iOSAT has been FDA NDA-approved since 1982. You can verify this by searching NDC 51803-001 on the FDA's DailyMed database. It is one of only three FDA-approved potassium iodide products currently available in the United States.
iOSAT has a manufacturer-guaranteed shelf life of 10 years — the longest in the industry. According to the NRC, potassium iodide tablets are "inherently stable" and testing through the FDA's SLEP program has shown potency is maintained well beyond the labeled expiration when properly stored.
Yes, but the 130mg tablet must be split for pediatric doses. Children 3-12 need half a tablet (65mg), children 1 month to 3 years need a quarter tablet (32mg). For easier pediatric dosing without splitting, consider ThyroSafe 65mg tablets.
iOSAT is an FDA-approved drug manufactured under NDA standards, which requires more rigorous quality control, potency verification, stability testing, and regulatory compliance than dietary supplements. The price reflects the government-grade quality assurance, individual foil sealing, and 10-year shelf life guarantee.
Store in its original sealed foil packaging at room temperature (59-86°F) in a dry location away from direct light. A bedroom closet or dedicated emergency supplies shelf works well. Avoid bathrooms (humidity) and garages (temperature extremes).